Israel Agranat

11PUBLICATIONS
2CO-AUTHORS
Medicinal and biomolecular chemistry not elsewhere classifiedCorporations and associations lawBiologically active moleculesOther creative arts and writing not elsewhere classifiedSeparation technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 14, 2026
Drug law versus common parlance of medicinal chemists on "new chemical entity" of novel drug designations.

|Jan 14, 2026
Perspectives of Patents in Academic and Industrial Collaborations in Drug Discovery.

Israel Agranat, Hava Ercegovic

|Oct 09, 2025
Consecutive double chiral-switches strategy. ADHD methylphenidate drugs: from two racemates via racemate to enantiomer.

Israel Agranat, Ilaria D'Acquarica

|Jul 16, 2025
The Importance of Correct New Drug Designations: New "Novel Drug Entity" Designations.

Sarah K Branch, Israel Agranat

|Feb 19, 2025
Erratum: Addition to "The Death of the Strategy of Classical Chiral Switches Is an Exaggeration".

Israel Agranat, Ilaria D'Acquarica

|Feb 11, 2025
A call to develop tramadol enantiomer for overcoming the tramadol crisis by reducing addiction.

Ilaria D'Acquarica, Israel Agranat

Pageof 2

Frequent Collaborators

7 joint publications

Ilaria D'Acquarica

1 joint publications

Sarah K Branch